Predicting The Turn W/ Dave Knox

Started in 2017, Ro is a health care technology company building a patient-centric healthcare system. The pandemic gave rise to a remarkable time of growth for the company, marked by the rise of telehealth and multiple acquisitions by the business. Since just this spring, Ro has launched a one of kind in-home vaccination program, raised $500M in funding, acquired two companies (Modern Fertility and diagnostics startup Kit), and premiered its products across 97% of Walmart stores in the US. I sat down with Rob Schutz, Chief Growth Officer and Co- Founder of Ro, to talk about the company’s growth trajectory, the boom of telehealth during COVID, and their new national rollout with Walmart.